Clinical Trials Browser

Phase 1 × rovalpituzumab tesirine × Clear all

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03086239 2021-08-03

A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer

Phase 1 Completed

29 enrolled

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT02819999 2020-03-12

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Phase 1 Terminated

28 enrolled

Thoracic

Small Cell Lung Carcinoma

Clinical Trials

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer